RNO Insider Trading

Insider Ownership Percentage: 74.58%
Insider Buying (Last 12 Months): A$10,384.29
Insider Selling (Last 12 Months): A$0.00

Rhinomed Insider Trading History Chart

This chart shows the insider buying and selling history at Rhinomed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rhinomed Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for RNO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Rhinomed Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/2/2024Michael JohnsonInsiderBuy130,165A$0.03A$3,384.29
9/5/2023John McBainInsiderBuy100,000A$0.07A$7,000.00
5/3/2023Michael JohnsonInsiderBuy55,555A$0.07A$3,999.96
5/6/2022Eric KnightInsiderIssued7,847A$0.19A$1,490.93
4/19/2022John McBainInsiderIssued4,868,214A$0.19A$924,960.66
3/4/2022Ronald (Ron) DewhurstInsiderBuy100,000A$0.22A$22,000.00
2/3/2022Michael JohnsonInsiderTransfer2,700,000A$0.32A$861,300.00
12/20/2021Michael JohnsonInsiderExercise3,000,000A$0.29A$861,000.00
7/2/2021John McBainInsiderBuy487,921A$0.16A$77,091.52
6/24/2021John McBainInsiderBuy506,167A$0.15A$75,925.05
See Full Table

SEC Filings (Institutional Ownership Changes) for Rhinomed (ASX:RNO)

1.09% of Rhinomed stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. The company offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. Its products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. The company also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Cremorne, Australia.
Read More on Rhinomed

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

452,773 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

3.01%

Beta

0.88

Who are the company insiders with the largest holdings of Rhinomed?

Rhinomed's top insider investors include:
  1. John McBain (Insider)
  2. Michael Johnson (Insider)
Learn More about top insider investors at Rhinomed.